CorMedix Inc.
Price Action
Technical Summary
WEAKENINGCorMedix Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 37), showing significant lag compared to the market leaders. Earnings growth of 40% provides fundamental context to the price action. Investors should exercise caution due to high volatility (65% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $8.45 | -9.60% | BELOW |
| 50 SMA | $8.06 | -5.17% | BELOW |
| 100 SMA | $7.52 | +1.65% | ABOVE |
| 150 SMA | $8.29 | -7.86% | BELOW |
| 200 SMA | $9.02 | -15.32% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CRMD in an uptrend right now?
CRMD has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is CRMD overbought or oversold?
CRMD's RSI (14) is 40. The stock is in neutral territory, neither overbought nor oversold.
Is CRMD outperforming the market?
CRMD has a Relative Strength (RS) Rating of 37 out of 99. CRMD is currently lagging the broader market.
Where is CRMD in its 52-week range?
CRMD is trading at $7.64, which is 51% of its 52-week high ($14.96) and 17% above its 52-week low ($6.13).
How volatile is CRMD?
CRMD has a Beta of 1.25 and 52-week volatility of 65%. It's more volatile than the S&P 500 - expect bigger swings.